Jennison Associates LLC Novo Nordisk A S Transaction History
Jennison Associates LLC
- $141 Billion
- Q1 2025
A detailed history of Jennison Associates LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Jennison Associates LLC holds 18,822,002 shares of NVO stock, worth $1.23 Billion. This represents 0.93% of its overall portfolio holdings.
Number of Shares
18,822,002
Previous 19,944,809
5.63%
Holding current value
$1.23 Billion
Previous $1.72 Billion
23.82%
% of portfolio
0.93%
Previous 1.06%
Shares
25 transactions
Others Institutions Holding NVO
# of Institutions
1,762Shares Held
340MCall Options Held
11.3MPut Options Held
15.5M-
Bank Of America Corp Charlotte, NC14.8MShares$966 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$809 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$804 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$775 Million0.36% of portfolio
-
Fayez Sarofim & CO Houston, TX11.2MShares$732 Million2.01% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $147B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...